3Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg, 1998, 85 : 1457-1459. 被引量：1
4Dolan K, Morris AI, Gosney JR, et al. Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease? J Gastroenterol Hepatol, 2004, 19: 24-30. 被引量：1
5Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries, lnt J Epidemiol, 2000, 29: 645-654. 被引量：1
6Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.Cancer, 1998, 83 : 2049-2053. 被引量：1
7Clements DM, Bowrey D J, Havard TJ. The role of staging investigations for oesophago-gastrie carcinoma. Eur J Surg Oncol,2004, 30:309-312. 被引量：1
8Mariette C, Castel B, Balon JM, et al. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur JSurg Oncol, 2003, 29: 588-593. 被引量：1
9Gianotti L, Braga M, Landoni L, et al. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy. Hepatogastroenterology, 2003,50 : 1948-1952. 被引量：1
10Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocareinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol,2005,90:139-146. 被引量：1
